West Bancorporation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.63M Buy
6,597
+5,993
+992% +$7.07M 2.99% 12
2026
Q2
$724K Sell
604
-66
-10% -$67.4K 0.31% 46
2026
Q1
$616K Sell
670
-44
-6% -$44.6K 0.31% 47
2025
Q4
$767K Sell
714
-24
-3% -$22.9K 0.4% 41
2025
Q3
$563K Buy
738
+37
+5% +$27.5K 0.31% 49
2025
Q2
$546K Buy
701
+136
+24% +$106K 0.35% 47
2025
Q1
$467K Buy
565
+196
+53% +$163K 0.32% 48
2024
Q4
$285K Hold
369
– – 0.19% 64
2024
Q3
$327K Hold
369
– – 0.22% 61
2024
Q2
$334K Sell
369
-2
-0.5% -$1.6K 0.25% 55
2024
Q1
$289K Hold
371
– – 0.19% 67
2023
Q4
$216K Buy
+371
New +$217K 0.14% 88
2022
Q4
– Sell
-371
Closed -$120K – 177
2022
Q3
$120K Hold
371
– – 0.09% 129
2022
Q2
$120K Hold
371
– – 0.08% 134
2022
Q1
$106K Hold
371
– – 0.07% 144
2021
Q4
$102K Buy
+371
New +$94K 0.08% 121
2020
Q3
$52K Hold
353
– – 0.06% 134
2020
Q2
$58K Sell
353
-37
-9% -$5.68K 0.07% 126
2020
Q1
$54K Sell
390
-180
-32% -$24.7K 0.08% 121
2019
Q4
$75K Buy
+570
New +$66.1K 0.08% 121

Other funds holding LLY

West Bancorporation's LLY Position: Q3 2026 in Review

West Bancorporation increased its Eli Lilly (LLY) stake by 992% in Q3 2026, buying an estimated $7.07M and bringing the position to 6,597 shares worth $7.63M. The position accounts for 2.99% of the portfolio, ranked #12.

West Bancorporation first reported a position in LLY in Q4 2019 and has held it in 20 quarters since. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • West Bancorporation held 6,597 shares of Eli Lilly worth $7.63M as of Q3 2026.
  • West Bancorporation bought 5,993 Eli Lilly shares in Q3 2026, an estimated $7.07M.
  • Eli Lilly made up 2.99% of West Bancorporation's portfolio in Q3 2026, its #12 holding.
  • West Bancorporation first reported a position in Eli Lilly in Q4 2019 and has held it in 20 quarters since.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on West Bancorporation's 13F filing for Q3 2026, filed 29 Oct 2026.